Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice
about
IFITM3 inhibits influenza A virus infection by preventing cytosolic entryThe dispanins: a novel gene family of ancient origin that contains 14 human membersEvolution of vertebrate interferon inducible transmembrane proteinsA novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factorPhenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutationBone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfectaNew genes in bone development: what's new in osteogenesis imperfectaOsteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessmentIfitm3 limits the severity of acute influenza in miceEvolutionary dynamics of the interferon-induced transmembrane gene family in vertebratesA mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.Regulation of the trafficking and antiviral activity of IFITM3 by post-translational modifications.HIV-1 mutates to evade IFITM1 restriction.Phenotype and genotype analysis of Chinese patients with osteogenesis imperfecta type V.Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells.Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutationThe IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type VA single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V.Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation.IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus.Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.Interferon-induced transmembrane protein 3 is a type II transmembrane protein.Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans.Effects of the overexpression of IFITM5 and IFITM5 c.-14C>T mutation on human osteosarcoma cells.A brilliant breakthrough in OI type V.IFITMs restrict the replication of multiple pathogenic virusesIFITM-Family Proteins: The Cell's First Line of Antiviral Defense.IFITM5 mutations and osteogenesis imperfecta.PHENOTYPIC VARIABILITY IN INDIVIDUALS WITH TYPE V OSTEOGENESIS IMPERFECTA WITH IDENTICAL IFITM5 MUTATIONS.Characterization of chicken interferon-inducible transmembrane protein-10.The osteogenic cell surface marker BRIL/IFITM5 is dispensable for bone development and homeostasis in mice.Effects of targeted modulation of miR-762 on expression of the IFITM5 gene in Saos-2 cells.A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onset.Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function.Understanding the functional role of genistein in the bone differentiation in mouse osteoblastic cell line MC3T3-E1 by RNA-seq analysis.Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.Genetic causes and mechanisms of Osteogenesis Imperfecta.
P2860
Q21090493-76D4CABB-92BA-44A7-95AC-341D024BC89DQ21134765-D0D95B60-A6C0-4500-8900-D1087B6D25B7Q21266712-18FAFA58-A158-4050-A095-156344CEE2D4Q24336923-C2CA1550-CB92-4F78-973B-D7D83F209D82Q24610376-DCCBB595-0385-46C2-98B3-EAC04A62220EQ26862184-F75F66C4-619D-43CD-AE14-2E644E788215Q26864752-0A81483D-2469-46B3-8762-2EBF0D03E3F5Q27025005-789998B7-59F1-483E-AAA1-D3B285A74408Q27342563-3074DD28-0425-4C4A-95BA-3F55DA7D3DC6Q28712012-A0F2D1BC-C82B-40F5-A0E1-E57CA96C0FA3Q34292231-C68547A0-AF66-4A6E-861E-7123642C76DAQ34627384-63411E51-2400-4519-8C6A-DF4213DA8463Q34761788-E716B237-053A-47D2-BAEE-6F4FDDB3410CQ34973809-6CCAAD17-DE59-4197-9375-BF9342341EC2Q34995149-0AC9239A-FF86-4743-A2C5-D519D0DE5706Q35055113-6E6D353E-BD5C-4EAD-82A0-757996C2E003Q35096701-202856E5-9CCF-4213-AEEF-8D7A9909D3B0Q35132933-C3CE2A85-83B3-4B3B-8393-456C4510A323Q36152886-1838D61F-EFCA-43AF-8FCB-50D0E8ED1C2DQ36325726-4582D6A1-5C52-4689-9491-FE667262AD4BQ36832578-742EB683-F173-4676-90CC-E019DF759E62Q37036679-322EE2E1-417F-44E4-815D-4B8974570F0FQ37239444-40244F97-9C6C-4E9C-9CE1-FF3A91CF5159Q37289177-2B11C623-3299-4F36-AA44-2ED94C7C94A4Q37363516-7B4535A0-B3E4-4044-AB42-2BD0B7E4C5A0Q37594020-E3324EE0-44FB-4F0B-B324-36755D462B5DQ38136971-DA5D51F0-D9F3-4574-97EE-AF584C256B49Q38146443-9BE9DA5B-693D-42FA-958D-45B8CDF37647Q38323041-F3F07252-E026-42AD-A32C-86C8F793751BQ38511204-F800DEB6-7C23-4A17-937D-76AA9E29DD60Q38616531-82817269-4A7A-4B2B-986B-1599D9F19493Q40373315-C47BB2D2-CB30-4106-AE26-895FF3CAB6F4Q41569088-D138FD84-A29D-4509-AED9-AD573DF554A5Q41944843-EB76E773-B9CC-43F7-9810-7C99BF05092AQ42630989-353ADEE5-B920-46FE-8ABB-12CE57166B7DQ43415353-95152EDD-4643-48BD-8373-947B72E146F1Q49831206-000B7C14-E161-4060-8000-97B5AD03C096Q50172805-338A8774-28FE-49D6-AB1C-2F17D17E88A6Q52679260-5D540D63-E2AD-45D4-953D-E199814A6C13
P2860
Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice
description
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2011
@ast
scientific journal article
@en
vedecký článok (publikovaný 2011/05/01)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/05/01)
@nl
наукова стаття, опублікована в травні 2011
@uk
مقالة علمية (نشرت في مايو 2011)
@ar
name
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@ast
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@en
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@nl
type
label
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@ast
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@en
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@nl
prefLabel
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@ast
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@en
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@nl
P2093
P2860
P921
P1476
Characterization of the osteob ...... lysis of IFITM5-deficient mice
@en
P2093
Hiromi Morita
Nobutaka Hanagata
Takashi Minowa
Taro Takemura
Xianglan Li
P2860
P2888
P304
P356
10.1007/S00774-010-0221-0
P577
2011-05-01T00:00:00Z